Тактика при отсутствии эффекта от лечения

При отсутствии эффекта от лечения наружными ретиноидами, БПО или азелаиновой кислотой при легком течении папулопустулезных акне показана терапия комбинированными препаратами (адапален+БПО) или системная терапия антибиотиками в сочетании с адапаленом.

При отсутствии эффекта от антибиотикотерапии в сочетании с адапаленом, комбинацией адапалена с БПО или азелаиновой кислотой при среднетяжелых папулопустулезных/умеренных узловатых акне показан системный изотретиноин.

ПРОФИЛАКТИКА

Методов профилактики не существует.

Список литературы

1. Gollnick G. et al. Management of Acne. J Am Acad Dermatol 2003; 49: S1-38.

2. Webster G.F., Graber EM. Antibiotic treatment for acne vulgaris // Semin Cutan Med Surg, 2008. – Vol. 27(3). – P. 183-187.

3. Kircik LH. Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications // J Drugs Dermatol, 2010. – Vol. 9 (11). - P. 1407-1411.

4. Amin K., Riddle C.C., Aires D.J., Schweiger E.S. Common and alternate oral antibiotic therapies for acne vulgaris: a review // J Drugs Dermatol, 2007. – Vol. 6(9). – P. 873-880.

5. Maibach H.Lebrun-Vignes Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology // Cutis, 1991. – Vol. 48(5). – P. 411-417.

6. Самцов А.В. Акне и акнеиформные дерматозы. Монография – М.: OOO «ЮТКОМ», 2009. – 208 с.: ил.

7. Krunic et al. Efficacy and tolerance of acne treatment using both spironolactone and a cjmbined contraceptive containg drospirenone J Am Acad Derm 2008, 58: 60-62.

8. Koltun W, Maloney JM, Marr J, Kunz M. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis. Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):171-5. doi: 10.1016/j.ejogrb.2010.12.027. Epub 2011 Feb

9. Lucky AW, Koltun W, Thiboutot D. et al. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment. Cutis. 2008 Aug;82(2):143-50.

10. Frangos J., Alavian Ch., Kimball A. Acne and oral contraceptives: Update on women’s health screening guidelines. J Am Acad Dermatol 2008; 58: 781-786.

11. Thiboutot D, Gollnick H. New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne group.J Am Acad Dermatol 2009;60:1-50.

12. Dreno B, Layton A, Zouboulis C et al. Adult female acne:a new paradigm JEADV 2013;27:1063-1070.

13. Cunliffe WJ, van de Kerkhof PC, Caputo R. et al. Roaccutane treatment guidelines: results of an international survey. Dermatology. 1997;194(4):351-7.

14. Peck GL, Olsen TG, Butkus D et al. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol 1982; 6: 735–745.

15. Strauss JS, Rapini RP, Shalita AR et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10: 490–496.

16. Cunliffe W.J.et al. A comparison of efficacy and tolerability of adapalene 0,1% gel versustretinoin0,025% gel in patients with acne vulgaris: a meta-analysis of five randomized trial. Br. JDermatol. 1998; 139(Suppl. 52):48-56.

17. Millikan L.E. Pivotal clinical trials of adapalene in the treatment of acne JEurAcadDermatolVenereol. 2001; 15 (Suppl 3):19-22.

18. Waugh J. et al. Adapalene: a review of its use in the treatment of acne vulgaris.Drugs. 2004;64(13):1465-78.

19. Lucky A.et al. Efficacy and tolerance of adapalene cream 0 1% compared with its cream vehicle for the treatment of acne vulgaris. Cutis. 2001; 68:34-40.

20. Cunliffe W.J. et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.J Am AcadDermatol. 1997;36:S126-34.

21. Cunliffe W.J.et al.Randomised controlled trial of the efficacy and safety of adapalene gel 0,1% and tretinoin cream 0,05% in patients with acne vulgaris. Eur J Dermatol. 2002; 12:350-354.

22. Thiboutot D.M. et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.Arch Dermatol. 2006;142(5):597-602.

23. Cook-Bolden F. Subject Preferences for Acne Treatments Containing AdapaleneGel 0,1%:Results of the MORE trial. Cutis. 2006; 78(1 Suppl):26-33.

24. Gold L.S. The MORE trial:Effectiveness of AdapaleneGel 0,1% in Real-world Dermatology Practices. Cutis. 2006; 78(1 Suppl):12-18.

25. Gollnick HP, Graupe K, Zaumseil RP. [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies // J Dtsch Dermatol Ges 2004; 2: 841–847.

26. Hjorth N, Graupe K. Azelaic acid for the treatment of acne. A clinical comparison with oral tetracycline // Acta Derm Venereol Suppl (Stockh) 1989; 143: 45–48.

27. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports // Cutis 1996; 57: 20–35.

28. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin // Acta Derm Venereol Suppl (Stockh) 1989; 143:35–39.

29. Cunliffe WJ, Holland KT. Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne //Acta Derm Venereol Suppl (Stockh) 1989; 143: 31–34.

30. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538–544.

31. Sagransky M.et al. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert OpinPharmacother. 2009; 10(15):2555-2562.

32. Hughes B.R. et al. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne.ClinExpDermatol. 1992;17(3):165-168.

33. Dunlop K.J., Barnetson R.S.A comparative study of isolutrol versus benzoyl peroxide in the treatment of acne.Australas J Dermatol. 1995;36(1):13-15.

34. Borglund E. et al.Topical meclocyclinesulfosalicylate, benzoyl peroxide, and a combination of the two in the treatment of acne vulgaris.ActaDermVenereol. 1991;71(2):175-178.

35. Swinyer L.J. et al. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.Br J Dermatol. 1988;119(5):615-622.

36. Tucker S.B. et al. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.Br J Dermatol. 1984;110(4):487-492.

37. Burke B. et al. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.Br J Dermatol. 1983;108(2):199-204.

38. Lassus A.Local treatment of acne. A clinical study and evaluation of the effect of different concentrations of benzoyl peroxide gel.Curr Med Res Opin. 1981;7(6):370-373.

39. Cunliffe W.J., Holland K.T.The effect of benzoyl peroxide on acne.ActaDermVenereol. 1981;61(3):267-269.

40. Prince R.A. et al. Comparative trial of benzoyl peroxide versus benzoyl peroxide with urea in inflammatory acne.Cutis. 1982;29(6):638-640, 644-645.

41. Schutte H. et al. The short-term effects of benzoyl peroxide lotion on the resolution of inflamed acne lesions.Br J Dermatol. 1982;106(1):91-94.

42. Norris J.F. et al. A comparison of the effectiveness of topical tetracycline, benzoyl-peroxide gel and oral oxytetracycline in the treatment of acne.ClinExpDermatol. 1991;16(1):31-33.

43. Cunliffe W.J. et al. Chloramphenicol and benzoyl peroxide in acne. A double-blind clinical study.Practitioner. 1980;224(1347):952-954.

44. Lyons R.E.Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris.Int J Dermatol. 1978;17(3):246-251.

45. Hare P.J.Benzoyl peroxide gel compared with retinoic acid in acne vulgaris.Br J ClinPract. 1975;29(3):63-66.

46. Ede M.A double-blind, comparative study of benzoyl peroxide, benzoyl peroxide-chlorhydroxyquinoline, benzoyl peroxide-chlorhydroxyquinoline-hydrocortisone, and placebo lotions in acne.CurrTher Res Clin Exp. 1973;15(9):624-629.

47. Shahlita AR, Smith EB, Bauer E. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison. Arch Dermatol. 1984 Mar;120(3):351-5

48. Kuhlman DS, Callen JP. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris. Cutis. 1986 Sep;38(3):203-6.

49. Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis. 2010 Jan;85(1):15-24.

50. Katsambas A, Towarky AA, Stratigos J. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris. Br J Dermatol. 1987 Mar;116(3):387-91.

51. Keating G.M. Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel: A Review of its Use in the Treatment of Acne Vulgaris in Patients Aged ≥ 12 Years. Am J ClinDermatol. 2011;12(6):407-420.

52. Eichenfield L.E. et al. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: Efficacy and Safety.J Drugs Dermatol. 2010; 9(11):1395-1401.

53. Gold L.S. et al. A North American Study of Adapalene-Benzoyl Peroxide Combination Gel in the Treatment of Acne. Cutis. 2009; 84:110-116.

54. Tan J. et al. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients. J Dermatol. Treat. 2011; 22(4):197-205.

55. Gollnick H.P. et al. Adapalene–benzoyl peroxide, a unique fixed-dosecombination topical gel for the treatment of acne vulgaris:a transatlantic, randomized, double-blind, controlled studyin 1670 patients.Br J Dermatol. 2009; 161(5):1180-1189.

56. Feldman S.R. et al. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am AcadDermatol. 2011; 64(6):1085-1091.

57. Pariser D.M. et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007; 6(9):899-905.

58. Thiboutot D.M. et al. Adapalene-benzoyl peroxide, a fixed-dosecombination for the treatment of acne vulgaris:Results of a multicenter, randomized double-blind,controlled study. J Am AcadDermatol. 2007; 57:791-799.

59. Troielli P.A. et al. Community study of fixed-combination adapalene 0.1% and benzoyl peroxide 2.5% in acne. Skinmed. 2010; 8(1):17-22.

60. Poulin Y. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients withsevere acne vulgaris: results of a randomized controlled trial. Br J Dermatol. 2011; 164:1376–1382.

61. Thiboutot D., Gollnick H., Bettoli V. et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group. J Am AcadDermatol, 2009; 60:S1-50.

62. Nast A., Dreno B., Bettoli V. et al. European Evidence-based (S3) Guidelines for the Treatment of Acne. JEADV 2012; 26 (Suppl. 1):1–29.

63. Wolf J.E., Kaplan D., Kraus S.J. et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study // J Am Acad Dermatol. 2003 Sep;49(3 Suppl):S211-7.

64. Zhang J.Z., Li L.F., Tu Y.T., Zheng J.A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1% // J Dermatolog Treat. 2004 Dec;15(6):372-8.

65. Campbell J.L.Jr. A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris // J Drugs Dermatol. 2007;6(6):625-629.

66. Weiss J.S., Shavin J.S.Topical retinoid and antibiotic combination therapy for acne management // J Drugs Dermatol. 2004 Mar-Apr;3(2):146-54.

Date: 2015-11-15; view: 328; Нарушение авторских прав